Clinical Trial Update: Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-999 "After Multiple Oral Doses" in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of PBF-999 after multiple oral doses in healthy volunteers; the trial has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• PBF-999

Snippet

Sponsor: Palobiofarma SL | Conditions: Huntington Disease | Phase 1 | Status: TERMINATED